Almirall and Inserm Transfert enter into a licensing and research collaboration to develop innovative treatments for vitiligo

Almirall announces a collaboration with the University of Michigan to gain understanding of disease drivers in hidradenitis suppurativa

Almirall and IRB Barcelona announce a research collaboration to discover novel molecular glue therapeutics for severe skin diseases